IDAHO FALLS, Idaho, Oct. 31 /PRNewswire-FirstCall/ -- International Isotopes Inc. announces they have received their operating license from the Nuclear Regulatory Commission (NRC) for the Company’s Fluorine Extraction Process (FEP).
The Company acquired the exclusive patent technology for production of ultra pure inorganic fluoride gases in January 2004. Since then, the Company has hired staff, designed and constructed a state-of-the-art high-purity gas production facility, and has installed one of the most sophisticated fluoride gas analysis laboratories in the country. The NRC operating license is required before the Company may store and process sufficient quantities of depleted uranium tetrafluoride to support commercial scale fluoride gas production and is the last license or permit required before the Company can begin commercial fluoride gas production.
International Isotopes Inc. began construction of the FEP production plant earlier this year. Typical to any first of its kind production plant some technical design challenges and special material availability issues have resulted in minor delays to the project. Steve T. Laflin, President and CEO of the Company said, “The production plant is nearly complete. For the rest of the year we will focus on finishing construction and initial system operational testing, culminating in the first trial fluoride gas production runs sometime before the end of the year.”
The gas products produced through the Fluorine Extraction Process are ideally suited to specialty applications such as microelectronics and chemical vapor deposition processes where ultra high purity gases are required. In addition, the Company plans to research a host of additional potential strategic applications in areas such as pharmaceutical, energy propulsion, or agrochemical that could be enhanced by various fluorination reactions.
About International Isotopes Inc.
International Isotopes Inc. manufactures a full range of nuclear medicine calibration and reference standards, manufactures a range of cobalt-60 products such as teletherapy sources, and provides a wide selection of radioisotopes and radiochemicals for medical devices, calibration, clinical research, life sciences, and industrial applications. The Company also provides a host of analytical, measurement, recycling, and processing services on a contract basis to clients.
International Isotopes Inc. Safe Harbor Statement
Forward-looking statements in this press release relating to our FEP production plans and possible applications are made pursuant to the safe harbor provision of the federal securities laws. Information contained in forward-looking statements is based on current expectations and is subject to change. Actual results may differ materially from the forward-looking statements. Many factors could cause actual results to differ materially from the forward-looking statements. Readers are directed to read the risk factors detailed from time to time in our filings with the Securities and Exchange Commission, including our annual report on Form 10-KSB for the year ending December 31, 2004.
For More Information, Contact:
Steve Laflin, President and CEO
(208) 524-5300
International Isotopes Inc.
CONTACT: Steve Laflin, President and CEO of International Isotopes Inc.,+1-208-524-5300
Web site: http://www.intisoid.com/
